Drug
Tulisokibart
Tulisokibart: highest development phase Phase 3, developed by Merck. 4 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tulisokibart NCT06651281 | Phase 3 | Crohn Disease |
| SC Tulisokibart NCT06430801 | Phase 3 | Crohn's Disease |
| Tulisokibart NCT07861074 | Phase 2 | Noninfectious Intermediate, Posterior, or Panuveitis |
| Tulisokibart NCT07867938 | Phase 2 | Pulmonary Sarcoidosis |
Latest
Follow Tulisokibart on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.